Found: 23
Select item for more details and to access through your institution.
Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer.
- Published in:
- PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0267362
- By:
- Publication type:
- Article
Dynamic Assessment of Tissue and Plasma EGFR -Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Cancers Treated with EGFR-TKIs.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11353, doi. 10.3390/ijms231911353
- By:
- Publication type:
- Article
Pneumatosis intestinalis induced by targeted therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 1, p. 5, doi. 10.1007/s00432-022-04396-1
- By:
- Publication type:
- Article
An Open‐Label, Single‐Arm, Two‐Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e782, doi. 10.1634/theoncologist.2019-0490
- By:
- Publication type:
- Article
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 25, p. 2591, doi. 10.1111/1759-7714.15039
- By:
- Publication type:
- Article
Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell‐free DNA from non‐small‐cell lung cancer patients with leptomeningeal metastases.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 14, p. 1251, doi. 10.1111/1759-7714.14866
- By:
- Publication type:
- Article
Old age and EGFR mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 7, p. 654, doi. 10.1111/1759-7714.14786
- By:
- Publication type:
- Article
Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 2, p. 306, doi. 10.1007/s10637-023-01341-y
- By:
- Publication type:
- Article
Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0236503
- By:
- Publication type:
- Article
Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-95628-w
- By:
- Publication type:
- Article
Revisit of 1997 TNM Staging System—Survival Analysis of 1112 Lung Cancer Patients in Taiwan.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 1, p. 9, doi. 10.1093/jjco/hyl119
- By:
- Publication type:
- Article
Phase II Randomized Trial of Tri-weekly Versus Days 1 and 8 Weekly Docetaxel as a Second-line Treatment of Advanced Non-small Cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2005, v. 35, n. 12, p. 700, doi. 10.1093/jjco/hyi191
- By:
- Publication type:
- Article
Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.810124
- By:
- Publication type:
- Article
Should EGFR mutations be tested in advanced lung squamous cell carcinomas to guide frontline treatment?
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 4, p. 661, doi. 10.1007/s00280-014-2536-3
- By:
- Publication type:
- Article
Erlotinib in patients with advanced lung squamous cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 203, doi. 10.1007/s00280-012-1997-5
- By:
- Publication type:
- Article
Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17394-7
- By:
- Publication type:
- Article
Salvage surgery after definitive chemoradiotherapy through VATS for an initial unresectable locally advanced lung cancer: an alternative consolidative modality to radiotherapy?
- Published in:
- Surgical Case Reports, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40792-021-01227-2
- By:
- Publication type:
- Article
Pathological complete response after afatinib treatment of stage IV oligometastatic adenocarcinoma of the lung: the role of pulmonary surgery.
- Published in:
- Surgical Case Reports, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40792-019-0741-3
- By:
- Publication type:
- Article
Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY Study.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 4, p. 505, doi. 10.1007/s11523-023-00975-5
- By:
- Publication type:
- Article
Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 207, doi. 10.1007/s11523-021-00791-9
- By:
- Publication type:
- Article
Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY.
- Published in:
- Cancer Science, 2020, v. 111, n. 12, p. 4510, doi. 10.1111/cas.14655
- By:
- Publication type:
- Article